In accordance with Listing Rule 3.1, continuous disclosure requirements, Azure Healthcare Limited (ASX: AZV) wishes to update the market on recent financial developments including its expected profit result for the 6 months to 31 December 2013. Operating performance and Half financial year guidance The Company is pleased to report that it has recorded growth in its sales results for the months from July to November 2013 combined with continued overhead and operating cost efficiencies. Consequently the Company wishes to provide guidance now that anticipates a Net Profit After Tax for the 6 months ended 31 December 2013 in the range of $2.1 to $2.5 million when compared to the previous corresponding period of $0.64 million. This result is subject to the completion of audit activities that are expected to be completed by 28 February 2013.
AZV Price at posting:
22.5¢ Sentiment: Buy Disclosure: Held
